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INTRODUCTION
challenge for long-term insulin independence following islet transplantation in type 1 diabetes is occult hypoxic, inflammatory, and immune graft loss (11, 41, 44) . Anoxia The success of clinical islet transplantation for curing patients with type 1 diabetes mellitus is limited, despite from initial avascularity of the islet is particularly stressful to islet functions in a hyperglycemic context of a recent progress made with improved islet isolation or immunosuppressive regimens (35, (39) (40) (41) 43) . The wide-diabetic recipient (4, 10) . In fact, native islets in the pancreas have a rich glomerular-like vascular system that spread application of this attractive alternative to insulin therapy or pancreas transplantation is limited by donor consists of fine capillaries supplied by one to five feeding arterioles (30, 32) . Such a rich microvasculature in organ shortage and the requirement of two to three donor pancreata per recipient to achieve insulin indepen-pancreatic islets provides efficient delivery of oxygen and nutrients to islet cells and at the same time ensures dence. In fact, reports demonstrated that only a small fraction of transplanted islets successfully engraft, re-a rapid dispersal of pancreatic hormones into circulation. However, islets are avascular after isolation process. For sults confirmed by experimental islet transplantation where 50-70% of the transplanted islets are lost in the this reason, after transplantation, the survival and function of islets must rely on the reestablishment of new immediate posttransplantation period (10, 37, 40) . A main vessels in the grafts, to derive blood flow from the host streptozotocin-induced diabetic mice (53) and provided the proof-of-principle that VEGF overexpression stimu-vessel system (2, 50) . There is evidence that freely transplanted islets are associated with significantly lower islet lated graft angiogenesis and augmented islet revascularization. Moreover, VEGF increased functional β-cell revascularization than native islets in the pancreas, and that this problem occurs irrespective of whether islets mass by improving angiogenesis of isolated human and murine pancreatic islets (22) . Therefore, exploring strat-are transplanted intraportally in the liver (25) . Thus, it is critically important to maintain adequate microvascular egies of VEGF overexpression in pancreatic islets, to improve angiogenesis and graft function, may prove in-perfusion of oxygen and nutrient supplies to islets.
However, adequate microvascular perfusion to islets teresting. We aimed to develop strategies of VEGF overexpres-does not resume immediately after islet transplantation. It can take up to between 7 and 10 days for intragraft sion in rat pancreatic islets using gene therapy, with an adenovirus encoding the VEGF 165 gene, or a pharma-microvessels to form after islet transplantation; moreover, the reestablishment of intragraft blood perfusion cological approach with deferoxamine (DFO), an iron chelator used in the treatment of acute iron poisoning, can take even longer (>14 days) (18,50). This delay in reestablishing functional microvasculature in newly grafted chronic iron or aluminium overload, and diseases like thalasemia (29) . Previous in vitro studies have shown islets starves islet cells of oxygen and nutrients. Indeed, several studies have shown that newly transplanted islets that these two approaches allowed an efficient overexpression of VEGF in the β-cell line RINm5F and in pan-are hypoxic, causing islet cells to undergo apoptosis and/or necrosis, which affects the loss of functional βcreatic islets (23, 24, 48) . However, the adenoviral infection was proapoptotic and amounts of insulin mRNA in cell mass posttransplantation (18, 50) . In fact, despite transplanting a large number of islets (11,000 islets/kg β-cell lines (24) were lower than with DFO, which preserved β-cell line RINm5F viability and presented an body weight) per diabetic recipient, only about 30% of transplanted islets become stably engrafted, correspond-antiapoptotic effect (24) . Therefore, these data obtained in vitro in β-cells have suggested that DFO could be a ing to a total loss of about 70% of the functional islet mass in the early posttransplantation phase (2) . new alternative for increasing VEGF overexpression and improving islet revascularization during transplantation. The molecular mechanisms that underlie pancreatic islet revascularization remain poorly understood, but MATERIALS AND METHODS seem to be a complex multistep process regulated by several angiogenic factors (42, 50, 51) . Among these fac-Animals tors, vascular endothelial growth factor (VEGF) appears Experiments were performed in accordance with the to be the most potent growth factor regulating blood vesprinciples and guidelines of the French legislation on sel growth (15,52). Indeed, VEGF acts in the early phase animal welfare: Journal Official number 87-848. Wistar to stimulate the formation of new blood vessels from and Lewis rats were supplied by Janvier laboratory (Le preexisting ones (52); thereafter, it initiates the revascu-Genes St Isle, France). Rats were housed in standard larization of islets during transplantation (21). VEGF is collective cages, in a temperature-controlled room (23 ± mitogenic for endothelial cells in various in vitro and in 1°C) with a 12-h light:12-h darkness cycle. They were vivo systems (5, 8) , increases permeability of microvesfed with SAFE-A04 (Villemoisson-sur-Orge, France). sels (22) , and is expressed in islets (49) . However, Food and water were available ad libitum. VEGF expression in islet cells is transiently induced, followed by significant decline 2-3 days after transplan-In Vitro Study tation (50, 51) . Moreover, there is an impaired angiogenesis of islet grafts in diabetic patients, which contributes Islet Isolation and Purification. Pancreatic islets were isolated from 250-300 g male adult Wistar rats for to the absence of adequate islet revascularization under hyperglycemic conditions. Thus, rapid and adequate is-the in vitro study and from syngeneic Lewis rats for the in vivo study, to sustain immune reactions. The islet let revascularization would protect islet grafts from hypoxia-induced inflammation and necrosis, thereby im-isolation procedure was performed according to Sutton et al. (47) . Then islets were cultured at 37°C in humidi-proving long-term graft survival and providing better preservation of functional mass. Sigrist et al. (46) dem-fied air with 5% CO 2 in 48-well culture plates (CELL-STAR, Greiner Bio-one, Kremsmünster, Austria) for onstrated that local VEGF delivery to islet grafts improved the outcome of islet transplantation by enhancing viability, functionality, and VEGF secretion studies, or in 60 × 15-mm culture dishes (Becton Dickinson, Mey-islet revascularization. To improve islet graft vascularization, other studies have delivered human VEGF lan, France) for mRNA and protein extraction. Islets were cultured in medium M199 (Lonza) supplemented cDNA by adenoviral gene transfer to mouse islets, followed by transplantation under the renal capsule in with 10% heat-inactivated fetal calf serum (FCS, Cam-brex Bio Science, Verviers, Belgium), 1% of a mixture Moloney murine leukemia virus (M-MLV) reverse transcriptase and random hexamers (Fermentas GmbH, St. of penicillin (10,000 UI/ml), streptomycin (10 mg/ml), and amphotericin B (25 µg/ml) (AB/AM, Sigma).
Leon-Rot, Germany). Quantification of β-actin, Bax, and Bcl-2 mRNA was performed according to Langlois Adenoviral Infection. Two adenoviruses (Ad VEGF et al. (24 Enzyme Linked Immunosorbent Assay) and and Ad β-galactosidase, Cell Biolabs, San Diego, CA, was given as the ratio of integrated optical density with USA) were used to infect rat pancreatic islets. The ade-Bax or Bcl-2 to that with β-actin. noviral vector, Ad VEGF, was built from human adenovirus serotype 5 deleted for the E1 and E3 gene. Ad VEGF Protein Secretion. The culture medium was VEGF contained an expression including the mouse collected 1 and 3 days later and was stored at −20°C. VEGF 164 gene. The viruses produced were thus non-VEGF measurements were performed using the rat replicative.
VEGF elisa kit (Tebu-bio, Le Perray en Yvelines, Rat pancreatic islets were infected in vivo to spread France) for the pharmacological approach and the huthe infection to all islet cells as briefly described below.
man VEGF elisa kit (Bender MedSystems, Austria) for After distending the pancreatic duct with Hank's soluthe infection approach. Total protein concentration was tion (Lonza, Saint Beauzire, France) the pancreas was quantified according to Henkel and Bieger (16). The reisolated from other organs by several ligatures on the sults were expressed in pg/µg of total protein. spleen, stomach, lung, and duodenum. Adenoviral prep-
Hypoxia-Inducible Factor-1α (HIF-1α) Analysis Usaration [100 multiplicity of infection (MOI)] was in-
ing Western Blotting. Protein extract was obtained from jected under the portal vein. The pancreas was then re-200 islets and Western blotting was performed accordmoved and placed in Hank's solution at 4°C. After 45 ing to Langlois et al. (24) . HIF-1α was studied using min, islets were purified after collagenase digestion.
an anti-rat HIF-1α monoclonal antibody (1/1000, R&D The percentage of infected islets was determined us-Systems, Minneapolis, NM, USA). The integrated optiing a β-galactosidase reporter gene staining kit (Sigma) cal density of bands was quantified using the ImageJ 1 and 3 days after infection.
v.1.34 software and normalized against β-actin (anti-Deferoxamine. Deferoxamine mesylate (Sigma) was mouse β-actin monoclonal antibody, 1/5000, Santa Cruz solubilized in ultrapure water at 100 mmol/L. Islets were Biotechnology Inc., CA, USA). incubated in 10 µmol/L of DFO diluted in culture me-Immunohistochemistry of Insulin. Immunohistochemidium for 1 day and 3 days.
cal staining was performed on paraffin-embedded sec-Islet Viability. The current standard method, involvtions using the extravidin-biotin-peroxydase method ing fluorescein diacetate/propidium iodide (FDA/PI, (Sigma), with monoclonal antibodies specific for insulin Sigma), was used for assessing islet viability. Ten islets (Sigma), according to Maillard et al. (28) . Appropriate for each condition were randomly selected by two indepositive and negative controls were used. Analysis inpendent investigators. The ratio between green cells and volved about 20 islets per condition. red cells provides the percentage of viability.
In Vivo Study Islet Functionality. One and 3 days after treatment, 10 islets from each experimental condition were washed Islet Transplantation. Islet transplantation was carextensively and incubated in Krebs Ringer bicarbonate ried out in diabetic male Lewis rats weighing about 200 (KRB) solution with 0.5% FCS and 2.5 mmol/L glucose g and was induced by a single intraperitoneal injection (Sigma). Islets were then stimulated with KRB solution of streptozotocin (75 mg/ml, Sigma). Animals were concontaining 0.5% FCS and 25 mmol/L glucose. Each insidered diabetic after two consecutive blood glucose cubation step was performed for 90 min at 37°C in humeasurements of ≥ 3 g/L using the Glucose RTU test midified air with 5% CO 2 . Supernatants were collected (Biomérieux SA, Craponne, France). Immunohistology after each incubation and stored at −20°C. Insulin meaof the pancreas of streptozotocin rats confirmed that no surements were performed using a rat insulin enzyme insulin secreting cells are viable. This study consisted linked immunosorbent assay (ELISA) kit (Mercodia, of four animal cohorts: diabetic rats that underwent a Uppsala, Sweden). The stimulation index was calculated laparotomy and an intraportal injection of CMRL as a ratio of stimulated insulin secretion to basal insulin (Gibco, Illkirch, France) (sham group), transplanted diasecretion. Results are representative of three separate exbetic rats (control), transplanted diabetic rats with inperiments.
fected islets (ADE), and diabetic rats transplanted with islets preincubated with 10 µmol/L DFO. Before trans-Study of Apoptosis by Evaluating Bax/Bcl-2 mRNA Expression Using RT-PCR. After 1 and 3 days of treat-plantation, untreated and infected islets were incubated in medium M199 + 10% FCS + 1% AB/AM for 1 day ment, total cellular RNA was extracted from islets using Trizol Reagent (Sigma) and converted to cDNA using and islets subjected to DFO treatment were incubated for 3 days. After the incubation, 1,000 islet equivalents per kilogram of body weight were counted, washed, and prepared in 1 ml of CMRL before intraportal transplantation.
Metabolic Follow-up. Metabolic control was monitored for 60 days after transplantation. Before each measurement, rats were fasted overnight. Animal survival and body weight (expressed in grams) were first assessed. Then graft efficiency was determined using the ratio between fasting C-peptide level and glucose level (pmol of C-peptide/g of glucose). Blood fasting glycemia, measured using the glucose RTU test, was expressed in g/L, and C-peptide levels in plasma using a rat C-peptide ELISA kit (Mercodia) were expressed in Statistical in vitro analysis was performed with Sigmastat 3.10 (Systat Software, Richmond, CA, USA). Levels of significance for influence of treatments on 6.83%, n = 11 ( Fig. 2A, a, c, e ) and 3 days of culture pancreatic islets and for influence of the duration of ex-(91.38 ± 6.95% with DFO, n = 8; 89.71 ± 8.30% after periment were assessed by least significant difference adenoviral infection, n = 7; vs. 87.86 ± 11.50%, n = 7 ANOVA test with a post hoc Bonferroni correction. t-( Fig. 2A, b , d, f). Test was performed to assess the significance of influ-Amounts of proapoptotic (Bax, Fig. 2B ) factor ence of DFO treatment on HIF-1 expression. Then, for mRNA were significantly greater in infected islets than the in vivo study, repeated data on body weight and the control and DFO-treated islets 1 day (0.93 ± 0.15, n = 4 ratio C-peptide/glycemia were analyzed using linear vs. 0.40 ± 0.32, n = 5 and 0.33 ± 0.16, n = 3; p < 0.01) mixed models with SAS software. Variance-covariance and 3 days after treatment (0.86 ± 0.14, n = 4 vs. 0.28 ± models were used and the choice of the best-fitting vari-0.11, n = 5 and 0.31 ± 0.09, n = 3; p < 0.001). mRNA ance-covariance matrix was based on the AIC goodness amounts of the antiapoptotic factor Bcl-2 (Bcl-2, Fig.  of fit measure. Data are reported as mean ± SD. The in-2C) remained unchanged 1 day and 3 days after treatfluence of the duration of the experiment and that of ment in controls (from 0.54 ± 0.28 to 0.54 ± 0.17, n = the treatment are represented, respectively, with # and *. 5) and DFO-treated islets (from 0.44 ± 0.15 to 0.52 ± Finally, values of p < 0.05 were considered significant. 0.14, n = 4). However, Bcl-2 amounts were significantly greater after adenoviral infection in control and DFO-RESULTS treated islets (n = 4; p < 0.05); however, levels of Bcl-2 Adenoviral Infection Efficiency remained lower than those of Bax 3 days after treatment. Islet infection with adenoviral vectors proved effi-An immunohistochemical study of insulin showed cient for β-galactosidase transduction (Fig. 1) . The similar staining 1 day after treatment, whatever the exquantification of adenoviral infection after X-gal labelperimental condition (Fig. 3A, a, c, e ). However, insulin ing showed that 90% of islet cells were infected with staining in control islets (Fig. 3A, b ) and infected islets 100 MOI (Fig. 1A ) after 1-day treatment. This percent- (Fig. 3A , f) decreased after 3 days of culture; necrotic age was maintained after 3 days (Fig. 1B) . However, areas were also visible, although these were greater in only 20% of islet cells were infected using the ex vivo number in islets infected with ADE. Insulin staining and method and the labeling was localized to the periphery islet structure were maintained throughout the experiof islets. ment for islets treated with DFO (Fig. 3A, c and d) .
We also investigated islet function ( Fig. 3B) : the Evaluation of Islet Viability and Functionality stimulation index was significantly higher 1 day after culturing in the presence of 10 µmol/L DFO than that Islet viability was preserved with 10 µmol/L DFO treatment ( Fig. 2A,c and d) or adenoviral infection (Fig. observed with control and ADE-infected islets, from 3.74 ± 0.58 to 1.96 ± 0.83 and 2.03 ± 1.06, respectively 2A, e and f) compared with control ( Fig. 2A, a and b ) after 1 day (90.82 ± 6.05% with DFO, n = 11; 93.00 ± (p < 0.001). However, islet function for those treated with 10 µmol/L DFO decreased during the experiment 8.19% after adenoviral infection, n = 8; vs. 92.09 ± to levels that were similar to control conditions after 3 days of culture (1.91 ± 0.22 vs. 2.02 ± 0.45, n = 6). Moreover, adenoviral infection induced a significant decrease in function 3 days after treatment (1.15 ± 0.13, n = 4; p < 0.01).
VEGF and HIF-1α Analysis in Islets
No difference was observed in VEGF secretion (Fig.  4A ) between experimental conditions after 1 day of cul- ment (1.51 ± 0.31 vs. 0.42 ± 0.20 in control, n = 3; p < 0.01) (Fig. 4B) .
Metabolic Assessment
Analysis of rat survival showed that the transplantation of islets treated with ADE or DFO did not induce animal death (n = 9), whereas 50% (3/6) and 18% (2/11) of rats died in the sham and control groups, respectively. However, no animal deaths were observed in the control group until 30 days after transplantation, whereas deaths were recorded as early as day 7 in the sham group (1/6).
Analysis of body weight over the course of the experiment (Fig. 5A ) for each studied group showed an increase in body weight in controls (from 182 ± 11 g at 3 days to 200 ± 13 g at 60 days, n = 11), DFO (from 217 ± 6 g at 3 days to 247 ± 12 g at 60 days, n = 9), and ADE groups (from 200 ± 8 g at 3 days to 255 ± 19 g at 60 days, n = 9) compared with the sham group in which a decrease was observed (from 185 ± 6 g at 3 days to 158 ± 20 g at 60 days, n = 6). To confirm these results, ture (control: 2.42 ± 1.09, DFO: 2.21 ± 1.84, ADE: 2.49 ± 1.25 pg/µg total protein, n = 3). However, 3 days after treatment, amounts of VEGF were significantly higher in DFO and ADE conditions than in control conditions [7.95 ± 0.84 pg/µg total protein for DFO (n = 3), 11.26 ± 0.82 for ADE pg/µg total protein (n = 3) vs. 1.80 ± 1.10 pg/µg total protein for control (n = 4); p < 0.001]. of HIF-1α in the presence of DFO after 3 days of treat-mean rat body weights were studied for each group over after 3 days of study]. Before transplantation, the ratio measured in control, DFO and ADE groups was similar the course of the whole experiment (Fig. 5B) . The mean values were compared, showing that body weight mea-to that in sham rats. This improvement in insulin secretion was maintained throughout the experiment in DFO sured in animals infected with ADE was significantly higher than in the other groups, with 212.28 ± 2.45 g and ADE groups, with 113.27 ± 50.79 (n = 5) and 127.01 ± 19.99 pmol/g (n = 6), respectively, at 60 days. (n = 9) versus 201.78 ± 2.50 g for control (n = 11; p < 0.05), 199.67 ± 2.83 g for DFO (n = 9; p < 0.01) and
However, insulin secretion in control rats decreased to a similar level to that of the sham group 60 days after 193.63 ± 4.07 g for sham animals (n = 6; p < 0.001). No significant difference was observed between control, transplantation (52.24 ± 9.83 (n = 6) versus 36.89 ± 6.43 pmol/g (n = 6), respectively). Statistical analysis of the DFO, and sham groups.
Finally, we evaluated the insulin secretion capacity C-peptide/glycemia ratio for each group over the entire experiment ( Fig. 6B ) showed that insulin secretion was of transplanted animals during a fasting period, by measuring the ratio C-peptide/glycemia. The analysis of in-significantly greater in the ADE group (148.89 ± 10.59 pmol/g, n = 6) than in control (92.62 ± 10.34 pmol/g, sulin secretion during the experiment (Fig. 6A) showed that, whatever the treatment used, the ratio C-peptide/ n = 7; p < 0.01) and sham (51.89 ± 12.53 pmol/g, n = 6; p < 0.001) rats. Finally, improvement in graft function glycemia was twofold higher in transplanted animals than in sham animals immediately after transplantation in the DFO group was significantly greater than that observed in the sham group (109.81 ± 11.79 vs. 51.89 ± [115.31 ± 62.50 for control (n = 7), 131.35 ± 31.43 for DFO (n = 5), and 147.27 ± 45.34 for ADE (n = 6) ver-12.53 pmol/g, n = 5; p < 0.01), whereas no significant differences were obtained with control group. sus 41.39 ± 7.60 pmol of C-peptide/g of glucose (n = 6)
DISCUSSION
The formation of new microvasculature by capillaries sprouting at the site of islet transplantation is crucial for the long-term survival and function of the graft (4, 53) . This study confirmed the key role of VEGF in the improvement of islet engraftment efficiency (3, 46, 53) . Several authors have thus focused on developing strategies to overexpress VEGF in pancreatic islets using viral infection (6, 7) . However, VEGF is efficiently overexpressed by adenoviral infection (6, 12) , but there are several obstacles or safety risks associated with gene therapy, such as the transduction of unwanted cells, which is particularly relevant here, thus requiring fine-tuned transgene expression. A pharmacological approach in which DFO is used to enhance VEGF expression is more feasible for human use than gene therapy. However, the mechanism of DFO is a chelator of iron with a lot of metabolic effect into the metabolism. DFO mimics iron deficiency. Therefore, the utilization of DFO to enhance islet transplantation survival in vivo as a treatment is not relevant and the studies focus on the action of DFO in vitro before islet transplantation.
This in vitro study has confirmed that adenoviral infection represents an efficient process for overexpressing the VEGF gene in islets (9, 26, 33, 45) . However, it is essential to infect islets using an in vivo method, to ensure that the gene is present in all islets, as the efficiency of an ex vivo infection of islet cells enables only the confirmed results previously obtained in our laboratory on the β-cell line RINm5F (24) . Consequently, the use number of islets may have blurred treatment differences, with normoglycemia observed in all groups. of an adenoviral infection to overexpress VEGF may be deleterious for islet viability and function in vitro.
A study of rat survival, associated with glycemia findings, tended to confirm the beneficial effects islet Therefore, the development of a pharmacological approach, using DFO, constituted a new and easy method transplantation, despite the eventual toxicity of ADE on metabolic control in type 1 diabetes. Moreover, DFO for VEGF overexpression in all islet cells. In accordance with results previously obtained in β-cells (24), 10 and adenoviral infection may improve the long-term efficiency of the graft, due to VEGF overexpression. µmol/L DFO preserved islet viability and stimulated islet function. We demonstrated that the presence of DFO The increase in body weight in the adenoviral infection may be explained by greater insulin secretion than increases VEGF release by islets, due to an increase of hypoxia characterized by overexpression of HIF-1α pro-that observed with DFO treatment and standard transplantation, which is confirmed by the C-peptide/glyce-tein. Indeed, the expression of HIF-1α is regulated by prolyl hydroxylase (PHD) that requires molecular oxy-mia ratio. Body weight gain is a good marker for insulin secretion and action, occurring through its well-known gen as substrate and iron as a cofactor to function (13) . In normoxia, the alpha subunit of HIF-1 is a target for and crucial role in glucose storage in muscle and liver cells and its role in increasing fatty acid synthesis (20) . prolyl hydroxylation by HIF prolyl-hydroxylase, which makes HIF-1α a target for degradation by an E3 ubiqui-Thus, the gene therapy approach was significantly more efficient than the pharmacological approach. tin ligase, leading to quick degradation by the proteasome (17, 19) . Thus, the DFO, in chelating iron, prevents
Finally, this study confirmed the advantages of islet transplantation and the important role of VEGF in im-the proper functioning of the PHD and therefore the degradation of HIF-1α. Finally, the accumulation of HIF-proving islet viability. Moreover, despite adenovirus toxicity, a prolonged overexpression of VEGF leads to 1α stimulates the expression of VEGF and therefore angiogenesis.
the most efficient grafts. However, our pharmacological approach with DFO improved the metabolic control of The benefic effect of DFO is not only due to the improvement of islet revascul:arization. Vaithilingam et al. diabetic rats after transplantation, but to a lesser extent than with gene therapy.Histological studies performed (48) have demonstrated that DFO treatment improved the outcome of encapsulated transplanted human islets on the liver of the transplanted rat (data not shown) showed that while DFO induced short-term secretion of with independence of the revascularization process. Indeed, the anti-oxydant (36) and the anti-inflammatory VEGF at the beginning of the study, adeno maintained this overexpression all along the experiment. Moreover, (31) properties of DFO are well described in the literature and could explain the cumulative benefic effect of this result was confirmed with the immunohistochemistry of the vessels (lectin staining). Finally, functionality DFO during free islet transplantation.However, although VEGF overexpression was similar between the DFO and of islet using insulin staining showed that insulin secretion was maintained with DFO and ADE during the ADE groups, we observed transient overexpression of VEGF, lasting only 3 days, in islets treated with DFO study while no insulin secreting cells are present in control. (Langlois et al., unpublished data). By contrast, using adenovirus, VEGF overexpression was maintained for A pharmacological approach inducing VEGF overexpression may be an interesting tool to improve graft effi-14 days (Sigrist et al., submitted) . Several studies have demonstrated that the revascularization of islets occurs ciency. However, DFO may not be the best molecule to maintain successful islet transplantations long-term, as in the 7-10-day posttransplantation period. The transient overexpression period using DFO may then be insuffi-VEGF was not overproduced for the same duration as during adenoviral infection. Moreover, DFO acts via a cient to establish and maintain islet vascularization. However, it has been well documented that adenoviruses hypoxia pathway. Therefore, it will be interesting to identify other molecules that sustain VEGF overexpres-are characterized by complement activation, cytokine release, and subsequent vascular damage leading to a sys-sion already in use in humans and which could then be easily applied to human islet transplantation with no temic inflammatory response (27, 34, 38) , whereas DFO is known to protect cells against immune destruction safety risks. Other molecules overexpressing VEGF in islets and not employing a hypoxia pathway, like mersa-(31), oxidative stress (36) , and enhanced insulin internalization and biological actions (14,24), indicating that lyl (1), should be considered. the pharmacological approach is less risky.
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1,000 islet equivalents per kg body weight into the liver REFERENCES of diabetic rats constituted a good model for engraftment, because this relatively low quantity of islets al-
